跳至主要内容
临床试验/NCT01353144
NCT01353144已完成4 期

A Comparison of Two Therapeutic Strategies for the Treatment of Aspirin-associated Peptic Ulcers

Kaohsiung Veterans General Hospital.2 个研究点 分布在 1 个国家目标入组 178 人开始时间: 2007年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
178
试验地点
2
主要终点
Number of Participants in Whom Peptic Ulcer Was Healed

研究概览

简要总结

Esomeprazole plus aspirin compared with esomeprazole alone for the treatment of aspirin-related peptic ulcers.

详细描述

The aims of this study are to compare esomeprazole plus aspirin with esomeprazole alone in the treatment of aspirin-related ulcers.

Patients with aspirin-related peptic ulcers are randomized to receive esomeprazole (40 mg/day) plus aspirin (100 mg/day) or esomeprazole (40 mg/day) alone for 8 weeks. Follow-up endoscopy was carried out at the end of the eighth week. The primary end point was the healing of peptic ulcers.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • aspirin users who have a peptic ulcer confirmed by endoscopy

排除标准

  • serious medical illness (including cardiovascular events within 6 months before endoscopy)
  • acute gastrointestinal bleeding
  • a history of gastric or duodenal surgery
  • allergic to the study drugs
  • require long-term treatment with non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs), antiplatelet agents, or anticoagulant agents
  • pregnancy

研究组 & 干预措施

esomeprazole plus aspirin

Active Comparator

esomeprazole (40 mg/day) plus aspirin (100 mg/day) for 8 weeks

干预措施: aspirin (Drug)

结局指标

主要结局

Number of Participants in Whom Peptic Ulcer Was Healed

时间窗: 8 weeks

Number of participants in whom peptic ulcer was healed at week 8

次要结局

  • Number of Participants Deveoping Peptic Ulcer Bleeding(8 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ping-I (William) Hsu, M.D.

Professor

Kaohsiung Veterans General Hospital.

研究点 (2)

Loading locations...

相似试验